TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced November 18, 1988
TCL Archive Varmus: Why are scientific societies obstructing public access to research results? May 20, 2005
